Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
- PMID: 7895172
- DOI: 10.1016/s1074-7613(95)80040-9
Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
Abstract
An Epstein-Barr virus-encoded protein, LMP2, blocks the effects of surface immunoglobulin (slg) cross-linking on calcium mobilization and on lytic reactivation of EBV in latently infected and growth-transformed primary human B lymphocytes. In wild-type EBV-transformed cells, LMP2 is constitutively tyrosine phosphorylated and is associated with Lyn and Syk protein-tyrosine kinases (PTKs). Baseline Lyn PTK activity is substantially reduced, and slg cross-linking fails to activate Lyn, Syk, Pl3-K, PLC gamma 2, Vav, Shc, and MAPK. Syk, Pl3-K, PLC gamma 2, and Vav are constitutively tyrosine phosphorylated, and their tyrosine phosphorylation does not change following slg cross-linking. In contrast, cross-linking slg on cells transformed by LMP2 null mutant EBV recombinants triggers the same protein tyrosine kinase cascade as in noninfected B lymphocytes. These data are consistent with a model in which LMP2 is a constitutive dominant negative modulator of slg receptor signaling through its effects on Lyn, Syk, or regulators of these kinases.
Similar articles
-
Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.Infect Agents Dis. 1994 Apr-Jun;3(2-3):128-36. Infect Agents Dis. 1994. PMID: 7812651 Review.
-
Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.J Virol. 1998 Oct;72(10):7796-806. doi: 10.1128/JVI.72.10.7796-7806.1998. J Virol. 1998. PMID: 9733815 Free PMC article.
-
An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.J Virol. 1991 Jul;65(7):3681-92. doi: 10.1128/JVI.65.7.3681-3692.1991. J Virol. 1991. PMID: 1710288 Free PMC article.
-
An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):772-6. doi: 10.1073/pnas.91.2.772. Proc Natl Acad Sci U S A. 1994. PMID: 8290598 Free PMC article.
-
Latent Membrane Protein 2 (LMP2).Curr Top Microbiol Immunol. 2015;391:151-80. doi: 10.1007/978-3-319-22834-1_5. Curr Top Microbiol Immunol. 2015. PMID: 26428374 Review.
Cited by
-
EBV-associated diseases: Current therapeutics and emerging technologies.Front Immunol. 2022 Oct 27;13:1059133. doi: 10.3389/fimmu.2022.1059133. eCollection 2022. Front Immunol. 2022. PMID: 36389670 Free PMC article. Review.
-
K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.J Virol. 2015 Jul;89(14):7248-61. doi: 10.1128/JVI.00839-15. Epub 2015 May 6. J Virol. 2015. PMID: 25948739 Free PMC article.
-
Development of drugs for Epstein-Barr virus using high-throughput in silico virtual screening.Expert Opin Drug Discov. 2010 Dec;5(12):1189-203. doi: 10.1517/17460441.2010.524640. Expert Opin Drug Discov. 2010. PMID: 22822721 Free PMC article.
-
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro.J Virol. 2006 Jul;80(14):6764-70. doi: 10.1128/JVI.00433-06. J Virol. 2006. PMID: 16809282 Free PMC article.
-
Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation.J Virol. 2005 Jul;79(13):8655-60. doi: 10.1128/JVI.79.13.8655-8660.2005. J Virol. 2005. PMID: 15956608 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous